COMPAMED 2019

Hall 8a, booth H23.4

Surfix BV presents its state of the art nanocoatings for micro- and nanodevices such as biosensors and microfluidics. Our surface modification technologies provide your device with the desired surface properties, either uniform or patterned with superior spatial resolution. Our nanocoatings can be applied on various inorganic and polymer materials, and even inside microfluidic channels. Whether you require control of wettability (hydrophobic, hydrophilic), anti-biofouling or biofunctionalization, Surfix helps to exploit your device’s full potential. We are looking forward to meeting you.

Surfix’s photonic diagnostics platform with lab-level precision

Surfix’s mission is to advance global health by delivering accurate, accessible, and affordable diagnostic solutions for disease detection and management, specifically in underserved Point-of-Care (POC) testing segments.

To achieve this goal, Surfix has developed a photonic diagnostics platform that delivers exceptional sensitivity, accuracy, and a broad dynamic range. This cutting-edge technology enables diagnostics with precision surpassing traditional laboratory standards – a POCT with beyond lab-level precision.

Surfix’s objective is to continuously enhance the platform, ensuring it remains easy to use while offering reliable and sensitive detection of a wide array of biomarkers. By doing so, Surfix is committed to elevating healthcare standards and making advanced diagnostics accessible globally.

General Information

Surfix
IVAM member
Agro Business Park 2
6708PW Wageningen
Netherlands
Number of Employees: 25
Founding Year: 2011

Contact

Dr. L.M.W. Scheres
+31 85 488 1285

Latest news

Cancer diagnostics in transition: COMPAMED Innovation Forum 2025 provides insights into the future
02.04.2025 Cancer diagnostics is at a turning point: new technologies are fundamentally changing how we recognize, understand and treat diseases. This …